Neuberg Sehgal Path Lab, a leading name in diagnostic services, launched a cutting-edge cytogenetics testing technology at ...
Neuberg Sehgal PathLab introduces advanced cytogenetics testing for comprehensive cancer diagnosis and prenatal screening: Our Bureau, Mumbai Wednesday, February 4, 2026, 17:30 Hr ...
GNC, the worldwide leader in health and wellness, today announced the launch of the newly reformulated GNC AMP Wheybolic, the ...
Diversified science and technology company Danaher (NYSE:DHR) met Wall Streets revenue expectations in Q4 CY2025, with sales ...
Danaher Corporation (NYSE:DHR) Q4 2025 Earnings Call Transcript January 28, 2026 Danaher Corporation beats earnings ...
Q4 2025 Earnings Call January 28, 2026 8:00 AM ESTCompany ParticipantsJohn Bedford - Vice President of Investor ...
This technology has vast potential to help patients but remains underutilized and underappreciated. The tools are there. What’s lacking are harmonized controls, regulatory guidelines and database ...
Extracellular vesicles can provide a wealth of information, but these intriguing messengers are notoriously difficult to detect. This could be about to change. Extracellular vesicles (EVs) are a ...
12d
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of BD® Research Cloud 7.0, furthering the company's AI ...
Key opportunities in the Global Esoteric Testing Market include addressing rising chronic disease rates, demand for molecular diagnostics in personalized medicine, and expanding use of liquid biopsy ...
In the assessment of 12-month price targets, analysts unveil insights for Becton Dickinson, presenting an average target of $205.57, a high estimate of $215.00, and a low estimate of $190.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results